Press Releases from Charles River
   
 
 
   
   

Charles River Announces Second-Quarter 2008 Results

Downloadable version.

  • Second-Quarter Sales Increase 14.5% to $352 Million
  • Second-Quarter GAAP EPS Increase 29% to $0.71 and Non-GAAP EPS Increase 23% to $0.79
  • Raising 2008 Sales and Non-GAAP EPS Guidance, GAAP EPS Guidance Lowered
  • Agreement Signed to Acquire NewLab BioQuality AG
  • Increases Stock Repurchase Authorization by $200 Million

WILMINGTON, Mass.--(BUSINESS WIRE)--Aug. 5, 2008--Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the second quarter and first six months of 2008. For the quarter, net sales increased 14.5% to $352.1 million from $307.4 million in the second quarter of 2007. Both the Research Models and Services (RMS) and Preclinical Services (PCS) business segments reported significantly higher sales, with the RMS segment showing particular strength due to continued demand from pharmaceutical and biotechnology companies. Foreign exchange contributed 4.1% to the net sales growth.

Click here to read the full release.
   
Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
Jun 10 - Identifying Fungal Contamination i...
May 06 - Artifacts of Virus Filter Validati...
Jun 21-Jun 25 - Chicago, IL - American Diabetes Association’s 73rd Scientific Sessions
Sep 12-Sep 13 - Germantown. MD - Developing and Implementing Effective SOPs
Jun 28-Jun 28 - Frankfurt, Germany - Seminar: Health Monitoring of Laboratory Animals

Charles River Laboratories, Inc.